• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov21
Chemomab Therapeutics released FY2025 Q3 earnings on November 20 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2819 (forecast USD -0.22)
04:00
Chemomab Therapeutics released FY2025 9 Months Earnings on November 20, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.2197
04:00
Aug15
Chemomab Therapeutics released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.355 (forecast USD -0.04)
03:00
Chemomab Therapeutics released FY2025 Semi-Annual Earnings on August 14 (EST), with actual revenue of USD 0 and EPS of USD -0.9359
03:00
Jul1
Chemomab Therapeutics Ltd. Holds Annual General Meeting
20:06
Jun30
Chemomab Therapeutics' nebokitug Phase II Trial Results Positive
12:00

Schedules & Filings

Schedules
Filings
Nov20
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -1.742 M, EPS -0.2819

Aug26
Reverse Stock Split(EST)

1-for-4 Reverse Stock Split

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.057 M, EPS -0.355

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MGRT
13.050
+143.93%
+7.700
PCSA
6.680
+122.30%
+3.675
YCBD
2.270
+58.74%
+0.840
ATPC
0.1408
+56.44%
+0.051
VYNE
0.6000
+48.99%
+0.197
ANDG
23.500
+46.88%
+7.500
ISPO
4.170
+46.83%
+1.330
MDLN
41.000
+41.38%
+12.000
CGTL
1.250
+31.30%
+0.298
GLIBR
8.490
+29.03%
+1.910
View More